Literature DB >> 2156604

Correlation between histologic grade of malignancy and copy number of c-erbB-2 gene in breast carcinoma. A retrospective analysis of 176 cases.

H Tsuda1, S Hirohashi, Y Shimosato, T Hirota, S Tsugane, S Watanabe, M Terada, H Yamamoto.   

Abstract

A system of histologic grade of malignancy in human breast carcinoma was devised by significantly modifying the way of evaluating number of mitoses and architectural atypia in the histologic grading of Bloom and Richardson. The modified grading system was applicable to all histologic subtypes of adenocarcinoma and showed a good association with prognosis of breast carcinoma patients in retrospective analysis of 176 consecutive surgical cases (P less than 0.0001). Of the three components of histologic grade, architectural atypia and number of mitotic figures independently had a significant effect on the prognosis. The copy number of c-erbB-2, a prognostic factor independent of tumor size and nodal status, was strongly correlated with the histologic grade, number of mitotic figures, and degree of nuclear atypia (P less than 0.001, each). Cox's regression model analysis showed that nodal status and histologic grade were two determinants of prognosis, and the independent effect of c-erbB-2 amplification was absorbed within that of the histologic grade. Although the importance of c-erbB-2 gene copy number seemed to be inferior to that of the histologic grade, both were shown to be strongly associated with the aggressiveness of the tumor itself rather than the extent of tumor spread.

Entities:  

Mesh:

Year:  1990        PMID: 2156604     DOI: 10.1002/1097-0142(19900415)65:8<1794::aid-cncr2820650821>3.0.co;2-y

Source DB:  PubMed          Journal:  Cancer        ISSN: 0008-543X            Impact factor:   6.860


  25 in total

1.  Relationship between c-erbB-2 immunoreactivity and thymidine labelling index in breast carcinoma in situ.

Authors:  D M Barnes; J S Meyer; J G Gonzalez; W J Gullick; R R Millis
Journal:  Breast Cancer Res Treat       Date:  1991-03       Impact factor: 4.872

2.  Clinical significance of the quantitative assessment of the cytosolic concentration of HER-2/neu protein in breast cancer by immunoenzymatic assay (ELISA).

Authors:  Maria D Corte; Juan A Rodil; Julio Vázquez; Lucia García; Juan C Rodríguez; Miguel Bongera; José C Fernández; Luis O González; Ma Luz Lamelas; Maite Allende; José L García-Muñiz; Antonio Fueyo; Francisco J Vizoso
Journal:  J Cancer Res Clin Oncol       Date:  2005-11-01       Impact factor: 4.553

3.  The correlations between HPV16 infection and expressions of c-erbB-2 and bcl-2 in breast carcinoma.

Authors:  Qian He; Shu-Qun Zhang; Yong-Lie Chu; Xiao-Li Jia; Xiang-Ling Wang
Journal:  Mol Biol Rep       Date:  2008-04-22       Impact factor: 2.316

4.  The prognostic value of c-erbB2 in primary breast carcinomas: a study on 942 cases.

Authors:  N Quénel; J Wafflart; F Bonichon; I de Mascarel; M Trojani; M Durand; A Avril; J M Coindre
Journal:  Breast Cancer Res Treat       Date:  1995-09       Impact factor: 4.872

5.  Cardiac safety of trastuzumab as adjuvant treatment for Japanese patients with early breast cancer.

Authors:  Mikiya Ishihara; Hirofumi Mukai; Shunji Nagai; Toru Mukohara
Journal:  Int J Clin Oncol       Date:  2009-10-25       Impact factor: 3.402

6.  Clinical Significance of Microcalcifications Detection in Invasive Breast Carcinoma.

Authors:  Yuki Hashimoto; Aya Murata; Naoki Miyamoto; Toshihiro Takamori; Yuta Hosoda; Yukari Endo; Yuka Kodani; Kengo Sato; Keiko Hosoya; Kiyosuke Ishiguro; Yasuaki Hirooka
Journal:  Yonago Acta Med       Date:  2015-08-18       Impact factor: 1.641

7.  Adrenocorticotropin-Producing Pituitary Carcinoma with Expression of c-erbB-2 and High PCNA Index: A Comparative Study with Pituitary Adenomas and Normal Pituitary Tissues.

Authors:  Vania Nose-Alberti; Maria Isabel S. Mesquita; Luciana C. Martin; Marcia J. Kayath
Journal:  Endocr Pathol       Date:  1998       Impact factor: 3.943

8.  Expression of p53 protein in benign epithelial hyperplasia, atypical ductal hyperplasia, non-invasive and invasive mammary carcinoma: an immunohistochemical study.

Authors:  Y Umekita; T Takasaki; H Yoshida
Journal:  Virchows Arch       Date:  1994       Impact factor: 4.064

9.  Immunohistochemical overexpression of C-erbB-2 in the prognosis of breast cancer.

Authors:  A Tsuchiya; N Katagata; I Kimijima; R Abe
Journal:  Surg Today       Date:  1993       Impact factor: 2.549

10.  Relationship between ERBB2 and E-cadherin expression in human breast cancer.

Authors:  J Palacios; N Benito; A Pizarro; M A Limeres; A Suárez; A Cano; C Gamallo
Journal:  Virchows Arch       Date:  1995       Impact factor: 4.064

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.